JEFFREY S MATHIESEN Insider Trading $GEMP NeuroBo Pharmaceuticals, Inc.

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for JEFFREY S MATHIESEN.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of JEFFREY S MATHIESEN. JEFFREY S MATHIESEN is Vice President and CFO in DELPHAX TECHNOLOGIES INC ($DLPX) and Director in NEUROONE MEDICAL TECHNOLOGIES Corp ($NMTC) and Director in Sun BioPharma, Inc. ($SNBP) and Chief Financial Officer in Gemphire Therapeutics Inc. ($GEMP).

Over the past year JEFFREY S MATHIESEN has been an insider in 2 companies. The total value of shares held by JEFFREY S MATHIESEN in these companies amounts to $63,443.

JEFFREY S MATHIESEN Vice President and CFO
DELPHAX TECHNOLOGIES INC
Chief Financial Officer
NeuroBo Pharmaceuticals, Inc.
Director
NEUROONE MEDICAL TECHNOLOGIES Corp
Director
Panbela Therapeutics, Inc.
$ 63443 The total value of shares held by JEFFREY S MATHIESEN
Insider Rank

JEFFREY S MATHIESEN ranks 31,231 out of 350,000 insiders. Go to Insider Ranking to see more.

JEFFREY S MATHIESEN in NeuroBo Pharmaceuticals, Inc.

Trading Symbol: GEMP
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of JEFFREY S MATHIESEN: Chief Financial Officer
Holdings: 14,134 shares
Current Value: $151,516
Latest Transaction: Jan 30 2018
$GEMP Market Capitalization: $97.34M
$GEMP Previous Close: $10.72

Last 4 weeks trend: STRONG BUY
Last 3 months trend: STRONG BUY

Last 3 Months Overview:
Buy: 6x
Sell: 0x
Shares Bought: 22,061
Shares Sold: 0
Share Difference: +22,061
Value Difference: -$154,951

Latest Insider Trading Transactions of JEFFREY S MATHIESEN in NeuroBo Pharmaceuticals, Inc.

1 Week2 Weeks1 Month3 Months6 Months1 Year2 Years
No. of Purchases0000000
Value of Purchases ($)0000000
No. of Sales0000000
Value of Sales ($)0000000

Sentiment: All, DLPX, GEMP, NMTC, SNBP

Page:   1

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Jan 30 2018GEMPGemphire Therapeut ...MATHIESEN JEFFREY SChief Financial Off ...Option ExerciseA10.1048,000484,80048,000
Aug 16 2017GEMPGemphire Therapeut ...MATHIESEN JEFFREY SChief Financial Off ...Option ExerciseM3.593,20711,5130
Aug 16 2017GEMPGemphire Therapeut ...MATHIESEN JEFFREY SChief Financial Off ...BuyM3.593,20711,51314,13410.9 K to 14.1 K (+29.35 %)
Aug 11 2017GEMPGemphire Therapeut ...MATHIESEN JEFFREY SChief Financial Off ...Option ExerciseM3.593,00010,7700
Aug 11 2017GEMPGemphire Therapeut ...MATHIESEN JEFFREY SChief Financial Off ...BuyM3.593,00010,77010,9277.9 K to 10.9 K (+37.85 %)
Aug 12 2016GEMPGemphire Therapeut ...MATHIESEN JEFFREY SChief Financial Off ...BuyP10.004,00040,0007,9273.9 K to 7.9 K (+101.86 %)
Aug 12 2016GEMPGemphire Therapeut ...MATHIESEN JEFFREY SChief Financial Off ...BuyP10.004,00040,0007,9273.9 K to 7.9 K (+101.86 %)
Aug 12 2016GEMPGemphire Therapeut ...MATHIESEN JEFFREY SChief Financial Off ...BuyC6.713,92726,3343,9270 to 3.9 K
Aug 12 2016GEMPGemphire Therapeut ...MATHIESEN JEFFREY SChief Financial Off ...BuyC6.713,92726,3343,9270 to 3.9 K
Aug 08 2016GEMPGemphire Therapeut ...MATHIESEN JEFFREY SChief Financial Off ...Option ExerciseA10.00210,0002,100,000210,000

Page:   1